
Company Info
Year Established2019
Contacts
Jennifer C. Cheng, Ph.D., J.D.Co-Founder & CEO
Company Description
PTM Therapeutics's Post Translational Modifications (PTMs) create more disease specific targets for therapeutic antibodies. PTM Therapeutics is striving to discover new targets and develop new therapeutics for the treatment of chronic diseases and cancer.